Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Price:
497.955
USD
8.05%
Market Cap:
$126.3B
Relative Value
The Relative Value of one
VRTX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 497.955 USD,
Vertex Pharmaceuticals Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VRTX Relative Value
HIDDEN
Multiples Across Competitors
VRTX Competitors Multiples
Vertex Pharmaceuticals Inc Competitors
Vertex Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.1B USD | 10.5 | 32 | 24.2 | 25.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
403.4B USD | 6.6 | 95.8 | 15.7 | 21.8 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.8B USD | 5.5 | 26.2 | 15 | 15 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.4B USD | 6.3 | 21.7 | 13.5 | 16.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD | 5.7 | 18.1 | 13.6 | 15.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69.4B AUD | 3.2 | 35.2 | 11.6 | 14.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39B EUR | 11.1 | 35.7 | 38.8 | 39.6 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
42.7B USD | 11.5 | 136.4 | 76.1 | 84.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
